← Evidence libraryUK-REBOA
Emergency Department Resuscitative Endovascular Balloon Occlusion of the Aorta in Trauma Patients With Exsanguinating Hemorrhage: The UK-REBOA Randomized Clinical Trial.
Jansen JO, Hudson J, Cochran C, et al. JAMA 2023 · PMID 37824132 · doi:10.1001/jama.2023.20850
Randomised trialManagementMajor trauma & polytraumaCitation checked
- Question
- Does adding REBOA to standard care in the emergency department reduce death in trauma patients with exsanguinating haemorrhage?
- Design
- Pragmatic Bayesian multicentre RCT in UK major trauma centres, funded by the NIHR.
- Patients
- Adult trauma patients with suspected exsanguinating haemorrhage below the diaphragm unresponsive to resuscitation.
- Intervention
- REBOA plus standard major trauma care
- Comparison
- Standard major trauma care alone
- Primary outcome
- All-cause mortality at 90 days
- Key result
- REBOA did not reduce mortality; the Bayesian analysis showed a high probability of harm, with more deaths, many occurring early from bleeding.
- Limitations
- Recruitment was smaller than planned and stopped early, and operators had limited REBOA experience, which may not reflect expert centres.
- Impact on practice
- Does not support routine emergency department REBOA in UK trauma care; haemorrhage control should focus on rapid definitive surgical or radiological intervention.